In our news section, you can find the stories, images, video clips, and people you need.
23 April 2015
Today the company raised its sales and earnings outlook for 2015 due to U.S. dollar appreciation. Currency developments in the first three months of the year have boosted Novozymes’ results. But the strength of the dollar can also have a downside.
Q1 in line with expectations; 2015 outlook adjusted for currencies
27 March 2015
Pursuant to company announcement no. 11, 2015, a reduction of the company’s B common stock by DKK 13,400,000 via cancellation of 6,700,000 treasury B stocks was adopted at the Annual Shareholders’ Meeting of Novozymes A/S on February 25, 2015.
| Copyright © 2015 Novozymes. All Rights Reserved.